News | October 24, 2007

Cordis Releases Next Generation Carotid Stent

October 25, 2007 - Cordis Corp. announced at TCT 2007 the U.S. and European launch of Cordis’s next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.

The PRECISE PRO RX Stent provides physicians with a broader range of treatment options for patients with carotid artery disease. It is the lowest profile system approved in the U.S. and among the lowest available in Europe. The PRECISE Stent is a small, wire-mesh tube that props open the blocked artery and may be used in conjunction with Cordis’ ANGIOGUARD Rx Emboli Capture Guidewire System- a tiny, basket-like device designed to trap particles of plaque, blood clot, or other material that may be dislodged in the carotid artery during stent placement.

The PRECISE PRO RX Stent System is FDA and CE Mark approved to treat carotid artery disease in patients at high risk for adverse events from carotid endarterectomy (CEA) - a surgical treatment for removing arterial plaque from the carotid artery. The Cordis PRECISE Stent is the only carotid system backed by a large, randomized clinical trial - the landmark SAPPHIRE study - to support the potential benefits of carotid artery stenting (CAS) in patients who are ineligible, or considered high-risk, for carotid endarterectomy.

For more information: www.cordis.com


Related Content

News | Stents Carotid

June 26, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home June 26, 2023
Home
News | Stents Carotid

May 1, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home May 01, 2023
Home
News | Stents Carotid

December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home December 13, 2022
Home
News | Stents Carotid

August 3, 2022 — Research from Ochsner Health published in the Journal of the American College of Cardiology is likely ...

Home August 03, 2022
Home
News | Stents Carotid
February 28, 2022 – InspireMD, Inc., a global developer of the CGuard Embolic Prevention Stent System (EPS) device for ...
Home February 28, 2022
Home
News | Stents Carotid

January 5, 2022 – A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for ...

Home January 05, 2022
Home
News | Stents Carotid

October 15, 2021 — The InspireMD CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid artery ...

Home October 15, 2021
Home
News | Stents Carotid

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

Home November 11, 2019
Home
News | Stents Carotid

June 13, 2019 — Silk Road Medical Inc. announced the presentation of real-world data for the treatment of patients with ...

Home June 13, 2019
Home
News | Stents Carotid

July 30, 2018 — Silk Road Medical Inc. recently announced the presentation of real-world data for the treatment of ...

Home July 30, 2018
Home
Subscribe Now